View Single Post
Old 03-21-2011, 06:58 AM   #6
1rarebird
Senior Member
 
Join Date: Feb 2010
Location: TN
Posts: 175
Re: thought this might make your day,week, year--the day may be approaching that some

I suspect that even with the additional cost for including a dual blockade drug like Tykerb or Lapatinib to Herceptin, it will be cost effective when the cost of a taxane is no longer needed. This sounds like it could be a winner for Her2+ patients as well for the insurance companies who would no longer be paying for the taxane.
--bird
__________________
Male Breast Cancer, DX 5/15/09, IDC, STAGE 1, 1.7 cm, HER2+++, ER+(95%)/PR+(75%), Ki67 40%, grade 3, 0/5 nodes, TX: mastectomy, TCH finished 7/19/10, radiation 6 wks., Tamoxifen on going, bisphosphonate 24 mos.
1rarebird is offline   Reply With Quote